CardioVascular BioTherapeutics Income Statement
View: Annual
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 13.6 | 14.8 | 9.6 |
| Depreciation & Amortization | 7.1 | 4.1 | 1.4 |
| Operating Income | (20.7) | (18.9) | (11.1) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | (7.1) | 19.3 | 0.3 |
| Nonoperating Expenses | 8.2 | 6.0 | 1.6 |
| Income Before Taxes | (36.0) | (5.6) | (12.4) |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | (36.0) | (5.6) | (12.4) |
| Continuing Operations | (36.0) | (5.6) | (12.4) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (36.0) | (5.6) | (12.4) |
| Total Net Income | (36.0) | (5.6) | (12.4) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.27) | (0.04) | (0.10) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
